Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) announced today the results of matters voted on at its annual meeting of the holders...
-
Finning Reports Q1 2026 Results
-
CALGARY, Alberta, May 12, 2026 (GLOBE NEWSWIRE) -- Total Energy Services Inc. (“Total Energy” or the “Company”) (TSX:TOT) announces its consolidated financial results for the three months ended...
-
MIDLAND, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- New Era Energy & Digital, Inc. (Nasdaq: NUAI) (“New Era” or the “Company”), a developer and operator of next-generation digital infrastructure...
-
SAN JOSE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) announced its plans for COMPUTEX Taipei 2026, June 2–5, at the Taipei Nangang Exhibition Center, where it...
-
SEOUL, South Korea, May 12, 2026 (GLOBE NEWSWIRE) -- DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher of digital games on mobile and...
-
- Duchenne (SGT-003): First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company’s Pediatric Investigation Plan from the European Medicines...
-
Utilization Gains Underpin Improving Same-Location RevenueFifth Asset Sale Under Asset Rotation StrategyReduced Leverage with $12.6 Million of PaydownsConference Call Will be Held on May 12, 2026, at...
-
Planned launch of ROLR-branded U.S. prediction markets product, supported by Crypto.com | Derivatives North America agreement, ROLR consumer website, Big 4 licensing advisor, applied AI capabilities...
-
400mg QD 5:2 selected as azenosertib monotherapy pivotal study dose based on favorable benefit-risk profile in DENALI Part 2a, supporting advancement in registration-intended trialsDENALI Phase 2...